Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Baxter
Boehringer Ingelheim
Dow
McKinsey

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Auranofin - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for auranofin and what is the scope of freedom to operate?

Auranofin is the generic ingredient in one branded drug marketed by Sebela Ireland Ltd and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for auranofin. One supplier is listed for this compound.

Recent Clinical Trials for auranofin

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Cancer Institute (NCI)Phase 2
Mayo ClinicPhase 2
The Aurum Institute NPCPhase 2

See all auranofin clinical trials

Recent Litigation for auranofin

Identify potential future generic entrants

District Court Litigation
Case NameDate
MERCK SHARP & DOHME CORP. v. APOTEX INC.2009-12-18

See all auranofin litigation

Medical Subject Heading (MeSH) Categories for auranofin
Synonyms for auranofin
(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold 2,3,4,6-tetraacetate
(1-Thio-beta-D-glucopyranosato)(triethylphosphine)gold2,3,4,6-tetraacetate
(2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranosato-kappaS(1))(triethylphosphine)gold
[1-(Thio-|ES)-|A-D-glucopyranose 2,3,4,6-tetraacetato](triethylphosphine)gold
2,3,4,6-Tetra-O-acetyl-1-thio-beta-D-glucopyranosato-S (triethylphosphine)gold
34031-32-8
AC1OCFGC
Auranofina
Auranofine
Auranofinum
Auroafen
BDBM50153291
CHEBI:2922
CHEMBL1366
DB00995
gold(+1) cation; (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane
gold(1+); (2S,3R,4S,5R,6R)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxane-2-thiolate; triethylphosphane
GTPL6306
Ridaura
Ridauran
SCHEMBL5188854
SK-39162
SK&F-39162
Triethylphosphine gold

US Patents and Regulatory Information for auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for auranofin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
Sebela Ireland Ltd RIDAURA auranofin CAPSULE;ORAL 018689-001 May 24, 1985   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Express Scripts
Mallinckrodt
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.